Noevir Holdings Co Ltd
TSE:4928
Noevir Holdings Co Ltd
Net Income (Common)
Noevir Holdings Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Noevir Holdings Co Ltd
TSE:4928
|
Net Income (Common)
¥7.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
5%
|
|
Shiseido Co Ltd
TSE:4911
|
Net Income (Common)
¥21.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Net Income (Common)
¥30.9B
|
CAGR 3-Years
32%
|
CAGR 5-Years
25%
|
CAGR 10-Years
13%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Net Income (Common)
¥9.7B
|
CAGR 3-Years
28%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
Kao Corp
TSE:4452
|
Net Income (Common)
¥43.9B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-4%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Net Income (Common)
¥20.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
See Also
What is Noevir Holdings Co Ltd's Net Income (Common)?
Net Income (Common)
7.5B
JPY
Based on the financial report for Dec 31, 2023, Noevir Holdings Co Ltd's Net Income (Common) amounts to 7.5B JPY.
What is Noevir Holdings Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
5%
Over the last year, the Net Income (Common) growth was -5%. The average annual Net Income (Common) growth rates for Noevir Holdings Co Ltd have been 12% over the past three years , -2% over the past five years , and 5% over the past ten years .